Aprea Therapeutics Inc (APRE)
5.19
-0.16
(-2.99%)
USD |
NASDAQ |
Apr 26, 16:00
5.00
-0.19
(-3.66%)
After-Hours: 20:00
Aprea Therapeutics Price: 5.19 for April 26, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 25, 2024 | 5.02 | 5.47 | 5.02 | 5.35 | 9079.00 |
Apr 24, 2024 | 5.37 | 5.37 | 5.065 | 5.17 | 6305.00 |
Apr 23, 2024 | 5.14 | 5.616 | 5.14 | 5.37 | 2657.00 |
Apr 22, 2024 | 5.752 | 5.752 | 5.120 | 5.120 | 11827.00 |
Apr 19, 2024 | 5.59 | 5.785 | 5.311 | 5.35 | 7291.00 |
Apr 18, 2024 | 5.610 | 5.610 | 5.61 | 5.61 | 998.00 |
Apr 17, 2024 | 5.71 | 5.848 | 5.71 | 5.73 | 2294.00 |
Apr 16, 2024 | 5.73 | 5.98 | 5.68 | 5.85 | 5097.00 |
Apr 15, 2024 | 6.00 | 6.007 | 5.70 | 5.90 | 8449.00 |
Apr 12, 2024 | 6.23 | 6.23 | 5.690 | 5.71 | 4652.00 |
Apr 11, 2024 | 5.867 | 6.16 | 5.85 | 5.90 | 4559.00 |
Apr 10, 2024 | 5.91 | 6.20 | 5.32 | 6.20 | 6691.00 |
Apr 09, 2024 | 5.90 | 6.31 | 5.90 | 6.039 | 7224.00 |
Apr 08, 2024 | 6.17 | 6.40 | 5.82 | 6.20 | 11661.00 |
Apr 05, 2024 | 6.27 | 6.475 | 6.00 | 6.30 | 9848.00 |
Apr 04, 2024 | 6.100 | 6.48 | 6.00 | 6.17 | 16916.00 |
Apr 03, 2024 | 6.67 | 6.70 | 6.30 | 6.67 | 10711.00 |
Apr 02, 2024 | 6.29 | 6.60 | 6.21 | 6.60 | 10056.00 |
Apr 01, 2024 | 6.64 | 6.64 | 6.13 | 6.35 | 4887.00 |
Mar 28, 2024 | 5.92 | 6.80 | 5.91 | 6.69 | 28785.00 |
Mar 27, 2024 | 6.31 | 6.31 | 5.95 | 6.07 | 16742.00 |
Mar 26, 2024 | 6.04 | 6.12 | 5.92 | 5.92 | 10140.00 |
Mar 25, 2024 | 6.105 | 6.20 | 5.945 | 6.084 | 10833.00 |
Mar 22, 2024 | 6.13 | 6.198 | 6.00 | 6.12 | 5207.00 |
Mar 21, 2024 | 6.625 | 6.625 | 5.88 | 6.35 | 51594.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.886
Minimum
Jul 10 2023
990.60
Maximum
Dec 27 2019
190.66
Average
55.20
Median
Jan 12 2022
Price Benchmarks
NeuBase Therapeutics Inc | 0.4327 |
Stoke Therapeutics Inc | 12.39 |
NovaBay Pharmaceuticals Inc | 0.0781 |
Palatin Technologies Inc | 1.815 |
iBio Inc | 1.76 |
Price Related Metrics
Price to Book Value | 1.662 |
Earnings Yield | -76.88% |
Market Cap | 28.18M |